vx5
Generic: anti-CXCL13 antibody·Code: VX5
vx5: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| VACCINEX, INC. (VCNX) | Preclinical |
Get deeper analysis on vx5
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis